Singapore markets close in 6 hours 3 minutes

Baxter International Inc. (BAX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
33.97-1.35 (-3.82%)
At close: 04:00PM EDT
33.95 -0.02 (-0.06%)
After hours: 07:43PM EDT

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000

IndustryMedical Instruments & Supplies
Full-time employees60,000

Key executives

NameTitlePayExercisedYear born
Mr. Jose E. AlmeidaChairman of the Board, President & CEO3.62MN/A1962
Mr. Joel T. GradeExecutive VP & CFO829.82kN/A1971
Ms. Heather KnightExecutive VP & Group President of Medical Products and Therapies1.63MN/A1972
Mr. Alok Sonig B.E., MbaExecutive VP & Group President of Pharmaceuticals1.56MN/A1972
Mr. Christopher A. TothExecutive VP & Group President of Kidney Care5.26MN/A1980
Ms. Tobi Karchmer M.D., M.S.Senior VP and Chief Medical & Scientific OfficerN/AN/AN/A
Mr. Charles Rusty PatelSenior VP & Chief Information OfficerN/AN/A1970
Ms. Clare TrachtmanVice President of Investor RelationsN/AN/AN/A
Mr. David S. RosenbloomExecutive VP & General Counsel776.51kN/A1960
Ms. Stacey Eisen?Senior Vice President, Chief Communications Officer & Corporate Marketing?N/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Corporate governance

Baxter International Inc.’s ISS governance QualityScore as of 1 July 2024 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.